Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
Business

Trump's Tariffs Are Targeting Indian Drugmakers. Americans Could Soon Pay More for Generic Medicines, CEO Warns

Erez Israeli, CEO of Dr. Reddy's Laboratories, said that President Donald Trump's proposed tariffs on imported generic medicines would inevitably translate into higher prices for patients. (Credit: Spencer Platt/Getty Images)

Americans could soon pay significantly more for generic prescription drugs under the Trump administration's new tariff policy, according to the chief executive of one of India's largest pharmaceutical manufacturers.

Erez Israeli, CEO of Dr. Reddy's Laboratories, told CNBC's Inside India that President Donald Trump's proposed tariffs on imported generic medicines would inevitably translate into higher prices for patients in the United States because manufacturers operate on razor-thin profit margins.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.